Who can use Lynparza(Olaparib)?

Lynparza is indicated for multiple cancer types with specific genetic biomarkers.

Approved Uses

It is used as maintenance therapy for advanced ovarian cancer with BRCA mutations or HRD-positive status, adjuvant treatment for high-risk early HER2-negative breast cancer with germline BRCA mutations, and treatment for metastatic breast, pancreatic, and prostate cancers with relevant genetic alterations. Patient selection must be confirmed through FDA-approved companion diagnostics.